Announcements Trials
Browse Landscape

Phase

Phase 2 94Phase 1 19Phase 1/2 13Phase NA 4Phase 3 4Phase EARLY_PHASE1 3Phase 4 3Phase 2/3 2

Status

Recruiting 2Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 31NETWORK 12OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 3

Conditions

Multiple Myeloma 3Recurrence 1Autoimmune Diseases of the Nervous System 1Anti-N-Methyl-D-Aspartate Receptor Encephalitis 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 182Docetaxel 166Gemcitabine 165Oxaliplatin 162Carboplatin 160Paclitaxel 152Leucovorin 122Drug Therapy 118Dexamethasone 118Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 56Neoadjuvant Therapy 53Lenalidomide 52Letrozole 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × OTHER × daratumumab × Clear all
NCT05675319 2026-01-05

AlloRelapseMM

Universitätsklinikum Hamburg-Eppendorf

Phase 3 Terminated
28 enrolled
Plasma cell

Multiple Myeloma

NCT06867991 2025-07-15

RADIA

The First People's Hospital of Changzhou

Phase 3 Recruiting
200 enrolled

Autoimmune Diseases of the Nervous System, Anti-N-Methyl-D-Aspartate Receptor Encephalitis

NCT03836014 2024-12-06

CONFIRM

Assistance Publique - HĂ´pitaux de Paris

Phase 3 Active not recruiting
436 enrolled
Plasma cell

Multiple Myeloma, Recurrence

NCT06187441 2024-08-19

HOVON174MM

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 3 Recruiting
599 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡